Impact Factor 3.519

Frontiers journals are at the top of citation and impact metrics

This article is part of the Research Topic

O-GlcNAcylation: Expanding the Frontiers

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Endocrinol. | doi: 10.3389/fendo.2018.00708

FGF23 Induction of O-Linked N-Acetylglucosamine Regulates IL-6 Upregulation And Secretion In Human Bronchial Epithelial Cells

 Stefanie Krick1, Eric S. Helton1, Samuel B. Hutcheson1,  Scott Blumhof1, Jaleesa M. Garth1, Rennan S. Zaharias1, Rebecca S. Denson1, 2, Hannah Wickham1, 2 and  Jarrod W. Barnes1*
  • 1University of Alabama at Birmingham, United States
  • 2University of Alabama, United States

The hexosamine biosynthetic pathway (HBP) generates the substrate for the O-linked -N-acetylglucosamine (O-GlcNAc) modification of proteins. The HBP also serves as a stress sensor and has been reported to be involved with nuclear factor of activated T-cells (NFAT) activation, which can contribute to multiple cellular processes including cell metabolism, proliferation, and inflammation.
In our previously published report, Fibroblast Growth Factor (FGF) 23, an important endocrine pro-inflammatory mediator, was shown to activate the FGFR4/phospholipase C (PLC)/nuclear factor of activated T-cells (NFAT) signaling in chronic inflammatory airway diseases such as cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).
Here, we demonstrate that FGF23 increased the O-GlcNAc modification of proteins in HBECs. Furthermore, the increase in O-GlcNAc levels by FGF23 stimulation resulted in the downstream activation of NFAT and secretion of interleukin-6 (IL-6). Conversely, inhibition of FGF23 signaling and/or O-GlcNAc transferase (OGT)/O-GlcNAc reversed these effects.
Collectively, these data suggest that FGF23 induced IL-6 upregulation and secretion is, at least, partially mediated via the activation of the HBP and O-GlcNAc levels in HBECs. These findings identify a novel link whereby FGF23 and the augmentation of O-GlcNAc levels regulate airway inflammation through NFAT activation and IL-6 upregulation in HBECs. The crosstalk between theseis signaling pathways may contribute to the pathogenesis of chronic inflammatory airway diseases such as COPD and CF as well as metabolic syndromes, including diabetes.

Keywords: O-GlcNAc, FGF23 = fibroblast growth factor 23, NFAT (nuclear factor expression of activated T cell), IL-6 (Interleukin 6), Inflammation

Received: 13 Sep 2018; Accepted: 09 Nov 2018.

Edited by:

Tony LEFEBVRE, Lille University of Science and Technology, France

Reviewed by:

Anna Krzeslak, University of Łódź, Poland
Yobana Perez-Cervera, Benito Juárez Autonomous University of Oaxaca, Mexico  

Copyright: © 2018 Krick, Helton, Hutcheson, Blumhof, Garth, Zaharias, Denson, Wickham and Barnes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: PhD. Jarrod W. Barnes, University of Alabama at Birmingham, Birmingham, United States, jbarnes@uabmc.edu